Professional word nerd; SEO content editor, onetime restaurant critic, ex-journo by choice; #amediting @MindyKB@dftba.club
Capital Region, NY
Joined August 2008
- Tweets22.8K
- Following368
- Followers228
- Likes27.7K
Holy shit, I can’t believe that actually worked! J&J maybe does have a shred of decency?
This quoted post is unavailable.
Mindy 🧷💜♠️ retweeted
I HAVE RETURNED TO MAIN because I am FURIOUS that @JNJGlobalHealth is preventing millions from accessing life-saving treatment with bedaquiline, thereby costing innumerable lives and increasing the global risk of multidrug-resistant tuberculosis. youtube.com/watch?v=tMhgw5SW…
Mindy 🧷💜♠️ retweeted
@JNJGlobalHealth, it's time to live up to your first credo: "We believe our first responsibility is to the patients, doctors and nurses, to mothers and fathers and all others who use our products and services."
#PatientsNotPatents
TAG joins TB survivors, advocates, researchers, clinicians, and civil society organizations to demand @JNJNews publicly commit to non-enforcement and withdrawal of all secondary patents on bedaquiline.
Read our open letter: treatmentactiongroup.org/let…
Mindy 🧷💜♠️ retweeted
How about..... not being needlessly terrible and ending the bedaquiline patent? @JNJNews @JNJGlobalHealth
#PatientsNotPatents
@johngreen
Mindy 🧷💜♠️ retweeted
Why do you think you have the right to deny access to life saving TB treatment @JNJGlobalHealth @JNJNews? The development of bedaquiline was publicly funded. You made money. Now stop restricting access to bedaquiline, we are #PatientsNotPatents.
ALT Screenshot of Wikipedia blurb for bedaquiline. The screenshot reads: "The public sector invested US$455–747 million in developing bedaquiline. This is thought to be 1.6× to 5.1× what the owner, Janssen Biotech, invested (estimated at US$90–240 million). If capitalized and risk-adjusted, these costs become US$647–1,201 million and US$292–772 million, respectively."